BAK

MKT CAP:$1B

Braskem S.A.

Market Cap

$1B

Basic Materials·Chemicals·🇧🇷 Brazil·NYSE

Materials·Chemicals·🇧🇷·NYSE

Stock Price

$3.46+$0.54 (+18.49%)

Apr 22, 2026

Company Details

Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells chemicals, including eth...

CEO

Roberto Prisco Paraíso Ramos

IPO Date

Jan 13, 1999

Website

www.braskem.com.br

Key Metrics TTM

Revenue

$14.0B

-1.5% YoY

Net Income

-$2.0B

EPS (Diluted)

-$5.07

Free Cash Flow

-$1.5B

Revenue / Share

$35.04

Gross Margin

2.2%

Operating Margin

-2.4%

Net Margin

-14.5%

FCF Margin

-10.6%

P/S

0.1x

P/E

—

Earnings Reports

Q1 2026

May 11, 2026

PENDING

FY 2025

Dec 30, 2025

$14.0BEPS -$4.90

Q4 2025

Mar 27, 2026

$3.0BEPS -$5.27

Q3 2025

Nov 12, 2025

$3.5BEPS -$0.01

Q2 2025

Jun 30, 2025

$3.6B-6.4%EPS -$0.13

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 20	$2.3B	$309M	-$201M
Q4 20	$3.8B	$995M	$228M
Q2 21	$5.3B	$2.0B	$1.8B
Q3 21	$5.7B	$1.7B	$1.4B
Q2 23	$3.6B	$92M	-$330M
Q3 23	$3.4B	$115M	-$123M
Q4 23	$3.4B	$203M	-$197M
Q1 24	$3.6B	$244M	-$8M
Q2 24	$3.8B	$280M	-$32M
Q1 25	$3.9B	$264M	$20M
Q2 25	$3.6B	$73M	-$193M
Q3 25	$3.5B	$88M	-$187M
Q4 25	$3.0B	-$117M	$23M

Valuation

Quarter	P/S	P/E
Q2 20	—	—
Q4 20	—	—
Q2 21	—	—
Q3 21	0.5x	4.5x
Q2 23	0.3x	2.1x
Q3 23	0.2x	2.0x
Q4 23	0.2x	—
Q1 24	0.3x	—
Q2 24	0.2x	—
Q1 25	0.1x	—
Q2 25	0.1x	—
Q3 25	0.1x	—
Q4 25	0.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 20	-$133M	-$248M
Q4 20	$774M	$606M
Q2 21	$506M	$358M
Q3 21	$1.2B	$991M
Q2 23	$399M	$216M
Q3 23	-$496M	-$743M
Q4 23	$204M	-$44M
Q1 24	$194M	$19M
Q2 24	$291M	$86M
Q1 25	-$470M	-$601M
Q2 25	-$57M	-$188M
Q3 25	-$138M	-$393M
Q4 25	-$182M	-$299M

Capital Expenditures

Quarter	CapEx
Q2 20	$115M
Q4 20	$167M
Q2 21	$148M
Q3 21	$165M
Q2 23	$183M
Q3 23	$247M
Q4 23	$248M
Q1 24	$175M
Q2 24	$205M
Q1 25	$132M
Q2 25	$131M
Q3 25	$255M
Q4 25	$117M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 23	+58.7%	+59.2%
Q3 23	-11.0%	-1.8%
Q4 23	-36.8%	-0.3%
Q1 24	-36.7%	-15.5%
Q2 24	+7.4%	-0.8%
Q1 25	+16.7%	+12.0%
Q2 25	+7.0%	+6.5%
Q3 25	-3.5%	+1.5%
Q4 25	-22.9%	-24.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 20	$998.3K	0.0%
Q4 20	$434.2K	0.0%
Q2 21	$584.7K	0.0%
Q3 21	$780.1K	0.0%
Q2 23	$805.9K	0.0%
Q3 23	-$201.5K	-0.0%
Q4 23	$604.4K	0.0%
Q1 24	$201.5K	0.0%
Q2 24	$1M	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q2 20	$11M	$85M	$90M
Q4 20	$16M	$118M	$97M
Q2 21	$12M	$119M	$93M
Q3 21	$15M	$130M	$110M
Q2 23	$16M	$112M	$100M
Q3 23	$19M	$138M	$84M
Q4 23	$23M	$123M	$106M
Q1 24	$21M	$131M	$93M
Q2 24	$21M	$118M	$90M
Q1 25	$25M	$134M	$105M
Q2 25	$22M	$141M	$104M
Q3 25	$24M	$118M	$106M
Q4 25	$21M	$135M	$102M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$429M	$88M	$517M
Q2 22	$367M	$147M	$514M
Q3 22	$437M	$93M	$530M
Q4 22	$2.5B	$462M	$3.0B
Q1 23	$492M	$152M	$644M
Q2 23	$553M	$98M	$651M
Q3 23	$549M	$203M	$752M
Q4 23	$2.9B	$998M	$3.9B
Q1 24	$2.9B	$798M	$3.7B
Q2 24	$2.9B	$628M	$3.5B
Q3 24	$2.4B	$487M	$2.9B
Q4 24	$3.0B	$360M	$3.4B
Q1 25	$2.3B	$345M	$2.6B
Q2 25	$1.9B	$226M	$2.1B
Q3 25	$1.3B	$150M	$1.5B
Q4 25	$2.1B	$269M	$2.4B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 20	398M	—	—
Q4 20	398M	-0.0%	—
Q2 21	398M	+0.0%	—
Q3 21	398M	+0.0%	—
Q2 23	398M	+0.1%	+0.1%
Q3 23	399M	+0.1%	+0.2%
Q4 23	399M	0.0%	+0.2%
Q1 24	399M	0.0%	+0.1%
Q2 24	399M	0.0%	+0.1%
Q1 25	398M	-0.0%	-0.0%
Q2 25	398M	+0.0%	-0.0%
Q3 25	398M	0.0%	-0.0%
Q4 25	399M	+0.0%	0.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 20	$283.9K	8K
Q4 20	$472.3K	8K
Q2 21	$666.0K	8K
Q3 21	$713.3K	8K
Q2 23	$412.7K	9K
Q3 23	$387.6K	9K
Q4 23	$392.4K	9K
Q1 24	$421.3K	9K
Q2 24	$448.5K	9K
Q1 25	$467.7K	8K
Q2 25	$429.2K	8K
Q3 25	$415.8K	8K
Q4 25	$353.6K	8K

Revenue / Employee